Clinical Management of Cytokine Release Syndrome in CAR-T Therapy

EP: 1.Rosie’s Journey with R/R MM

EP: 2.Overview of the Safety Profile of CAR-T Therapy

Now Viewing

EP: 3.Clinical Management of Cytokine Release Syndrome in CAR-T Therapy

EP: 4.Addressing Neurologic Toxicities in CAR-T Therapy: Monitoring, Management, and Patient Communication

EP: 5.Strategies for Managing Cytopenias and Infection Prophylaxis with CAR-T Therapy

EP: 6.Jackson’s Journey with High Risk R/R MM

EP: 7.Approach to Long-Term Management of CAR-T MM Patients

EP: 8.Importance of Multidisciplinary Approach in Care of CAR-T MM Patients

EP: 9.Real World Experience of CAR-T in MM Patients

EP: 10.Empowering Community Oncologists in the Era of CAR-T Therapy

Video content above is prompted by the following:

• Cytokine Release Syndrome (CRS) is a major concern in CAR-T therapy. How do you approach the grading and management of CRS?
• Which strategies have you found most effective for reducing the severity of CRS?
• Are there notable differences in CRS management protocols between ide-cel and cilta-cel?